PHIO PHARMACEUTICALS CORP. Increase (Decrease) in Prepaid Expense
PHIO PHARMACEUTICALS CORP. (PHIO) reported Increase (Decrease) in Prepaid Expense of -$46.00 thousand for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2016-05-12
- PHIO PHARMACEUTICALS CORP. increase (decrease) in prepaid expense for the quarter ending 2016-03-31 was -$46.00K.
- PHIO PHARMACEUTICALS CORP. increase (decrease) in prepaid expense for the quarter ending 2015-03-31 was -$91.00K.
- PHIO PHARMACEUTICALS CORP. increase (decrease) in prepaid expense for the quarter ending 2012-03-31 was -$128.00K.
- PHIO PHARMACEUTICALS CORP. increase (decrease) in prepaid expense for fiscal 2015 was -$131.00K, a 194.24% decline from fiscal 2014.
- PHIO PHARMACEUTICALS CORP. increase (decrease) in prepaid expense for fiscal 2014 was $139.00K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 12 month | Increase (Decrease) in Prepaid Expense 111 month |
|---|---|---|---|
| 2016-03-31 | -$46.00K 10-Q · filed 2016-05-12 | ||
| 2015-12-31 | -$131.00K 10-K · filed 2016-03-30 | ||
| 2015-03-31 | -$91.00K 10-Q · filed 2016-05-12 | ||
| 2014-12-31 | $139.00K 10-K · filed 2016-03-30 | ||
| 2012-03-31 | -$128.00K 10-Q · filed 2012-05-14 | $42.00K 10-Q · filed 2012-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |